• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPAR-微生物群-代谢器官三部曲调节生理机能。

The PPAR-microbiota-metabolic organ trilogy to fine-tune physiology.

机构信息

Interdisciplinary Graduate School, Institute for Health Technologies, Nanyang Technological University, Singapore.

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

出版信息

FASEB J. 2019 Sep;33(9):9706-9730. doi: 10.1096/fj.201802681RR. Epub 2019 Jun 25.

DOI:10.1096/fj.201802681RR
PMID:31237779
Abstract

The human gut is colonized by commensal microorganisms, predominately bacteria that have coevolved in symbiosis with their host. The gut microbiota has been extensively studied in recent years, and many important findings on how it can regulate host metabolism have been unraveled. In healthy individuals, feeding timing and type of food can influence not only the composition but also the circadian oscillation of the gut microbiota. Host feeding habits thus influence the type of microbe-derived metabolites produced and their concentrations throughout the day. These microbe-derived metabolites influence many aspects of host physiology, including energy metabolism and circadian rhythm. Peroxisome proliferator-activated receptors (PPARs) are a group of ligand-activated transcription factors that regulate various metabolic processes such as fatty acid metabolism. Similar to the gut microbiota, PPAR expression in various organs oscillates diurnally, and studies have shown that the gut microbiota can influence PPAR activities in various metabolic organs. For example, short-chain fatty acids, the most abundant type of metabolites produced by anaerobic fermentation of dietary fibers by the gut microbiota, are PPAR agonists. In this review, we highlight how the gut microbiota can regulate PPARs in key metabolic organs, namely, in the intestines, liver, and muscle. Knowing that the gut microbiota impacts metabolism and is altered in individuals with metabolic diseases might allow treatment of these patients using noninvasive procedures such as gut microbiota manipulation.-Oh, H. Y. P., Visvalingam, V., Wahli, W. The PPAR-microbiota-metabolic organ trilogy to fine-tune physiology.

摘要

人体肠道定植着共生微生物,主要是细菌,它们与宿主共同进化并处于共生关系中。近年来,肠道微生物群已经得到了广泛的研究,许多关于其如何调节宿主代谢的重要发现已经被揭示出来。在健康个体中,喂养时间和食物类型不仅可以影响肠道微生物群的组成,还可以影响其昼夜节律振荡。因此,宿主的喂养习惯会影响微生物衍生代谢物的产生类型及其在一天中的浓度。这些微生物衍生代谢物会影响宿主生理学的许多方面,包括能量代谢和昼夜节律。过氧化物酶体增殖物激活受体(PPARs)是一组配体激活的转录因子,可调节脂肪酸代谢等各种代谢过程。与肠道微生物群类似,各种器官中的 PPAR 表达呈昼夜节律性波动,研究表明,肠道微生物群可以影响各种代谢器官中的 PPAR 活性。例如,短链脂肪酸是肠道微生物群对膳食纤维进行厌氧发酵产生的最丰富的代谢物类型,是 PPAR 激动剂。在这篇综述中,我们强调了肠道微生物群如何调节关键代谢器官(即肠道、肝脏和肌肉)中的 PPAR。了解肠道微生物群会影响代谢并在代谢疾病患者中发生改变,这可能允许使用非侵入性程序(如肠道微生物群操作)来治疗这些患者。

相似文献

1
The PPAR-microbiota-metabolic organ trilogy to fine-tune physiology.PPAR-微生物群-代谢器官三部曲调节生理机能。
FASEB J. 2019 Sep;33(9):9706-9730. doi: 10.1096/fj.201802681RR. Epub 2019 Jun 25.
2
Crosstalk between PPARs and gut microbiota in NAFLD.PPARs 与肠道微生物群在非酒精性脂肪性肝病中的相互作用。
Biomed Pharmacother. 2021 Apr;136:111255. doi: 10.1016/j.biopha.2021.111255. Epub 2021 Jan 20.
3
Interactions between Host PPARs and Gut Microbiota in Health and Disease.宿主 PPAR 与肠道微生物群在健康与疾病中的相互作用。
Int J Mol Sci. 2019 Jan 17;20(2):387. doi: 10.3390/ijms20020387.
4
PPARs and Microbiota in Skeletal Muscle Health and Wasting.过氧化物酶体增殖物激活受体(PPARs)与骨骼肌健康和消耗中的微生物群。
Int J Mol Sci. 2020 Oct 29;21(21):8056. doi: 10.3390/ijms21218056.
5
A review of metabolic potential of human gut microbiome in human nutrition.人类肠道微生物群在人类营养中的代谢潜力综述。
Arch Microbiol. 2018 Mar;200(2):203-217. doi: 10.1007/s00203-017-1459-x. Epub 2017 Nov 29.
6
[Research progress on the regulation of mammalian energy metabolism by the circadian clock system and gut microbiota].昼夜节律系统和肠道微生物群对哺乳动物能量代谢调控的研究进展
Sheng Li Xue Bao. 2022 Jun 25;74(3):443-460.
7
Gut microbiota and host metabolism in liver cirrhosis.肝硬化中的肠道微生物群与宿主代谢
World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597.
8
The Role of the Gut Microbiota in Bile Acid Metabolism.肠道微生物群在胆汁酸代谢中的作用。
Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):s15-s20. doi: 10.5604/01.3001.0010.5494.
9
SCFA: mechanisms and functional importance in the gut.短链脂肪酸:在肠道中的作用机制和重要功能。
Proc Nutr Soc. 2021 Feb;80(1):37-49. doi: 10.1017/S0029665120006916. Epub 2020 Apr 2.
10
The diet-microbiota-metabolite axis regulates the host physiology.饮食-微生物群-代谢物轴调节宿主生理。
J Biochem. 2016 Jul;160(1):1-10. doi: 10.1093/jb/mvw022. Epub 2016 Mar 11.

引用本文的文献

1
Harnessing the Gut Microbiome in Cancer Immunotherapy: Mechanisms, Challenges, and Routes to Personalized Medicine-A Systematic Review.癌症免疫治疗中肠道微生物群的应用:机制、挑战及个性化医疗途径——一项系统综述
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251365700. doi: 10.1177/15330338251365700. Epub 2025 Aug 28.
2
Impact of the Gut Microbiota-Metabolite Axis on Intestinal Fatty Acid Absorption in Huainan Pigs.肠道微生物群-代谢物轴对淮南猪肠道脂肪酸吸收的影响
Microorganisms. 2025 Jul 8;13(7):1609. doi: 10.3390/microorganisms13071609.
3
Butyrate Produced by Gut Microbiota Regulates Atherosclerosis: A Narrative Review of the Latest Findings.
肠道微生物群产生的丁酸盐对动脉粥样硬化的调节作用:最新研究结果的叙述性综述
Int J Mol Sci. 2025 Jul 14;26(14):6744. doi: 10.3390/ijms26146744.
4
Targeting Catenibacterium mitsuokai with icariin modulates gut microbiota and improves hepatic lipid metabolism in intrauterine growth restriction.淫羊藿苷靶向米酒糖杆菌可调节肠道微生物群并改善宫内生长受限小鼠的肝脏脂质代谢
ISME J. 2025 Jan 2;19(1). doi: 10.1093/ismejo/wraf141.
5
Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects.过氧化物酶体增殖物激活受体α在神经退行性疾病和其他神经系统疾病中的作用:临床应用前景
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01371.
6
Interactions between Gut Microbiota, Host Circadian Rhythms, and Metabolic Diseases.肠道微生物群、宿主昼夜节律与代谢性疾病之间的相互作用
Adv Nutr. 2025 Jun;16(6):100416. doi: 10.1016/j.advnut.2025.100416. Epub 2025 Mar 24.
7
Captive environments reshape the compositions of carbohydrate active enzymes and virulence factors in wolf gut microbiome.圈养环境重塑了狼肠道微生物群中碳水化合物活性酶和毒力因子的组成。
BMC Microbiol. 2025 Mar 15;25(1):142. doi: 10.1186/s12866-025-03863-2.
8
Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction.依拉非尼在酒精性肝病中的治疗潜力:对巨噬细胞调节和纤维化减轻的见解。
World J Biol Chem. 2025 Mar 5;16(1):104535. doi: 10.4331/wjbc.v16.i1.104535.
9
Expression of PGC-1α, PPAR-α and UCP1 genes, metabolic and anthropometric factors in response to sodium butyrate supplementation in patients with obesity: a triple-blind, randomized placebo-controlled clinical trial.肥胖患者补充丁酸钠后PGC-1α、PPAR-α和UCP1基因的表达、代谢及人体测量学因素:一项三盲、随机、安慰剂对照临床试验
Eur J Clin Nutr. 2025 Mar;79(3):249-257. doi: 10.1038/s41430-024-01512-x. Epub 2024 Oct 24.
10
Sodium Butyrate, A Gut Microbiota Derived Metabolite in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Review.丁酸钠,一种源自肠道微生物群的代谢产物与2型糖尿病和心血管疾病:综述
Cardiovasc Hematol Agents Med Chem. 2025;23(1):1-10. doi: 10.2174/0118715257307380240820052940.